Skip to main content
Publications
Margulis AV , D'Onofrio B, Almqvist C, McElrath T, Oberg AS, Plana E , Rothman KJ , Hernandez-Diaz S. Antiepileptic drugs in pregnancy and duration of pregnancy, birth weight, length, and head circumference . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):234. doi: 10.1002/pds.4629
Saltus CW , Anthony MS , Armstrong MA, Postlethwaite D, Getahun D, Xie F, Gatz J, Grafton J, Merchant M, Ichikawa L, Fassett MJ, Schulze-Rath R, Asiimwe A. Validation of uterine perforation and intrauterine device expulsion in electronic health records . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):127-8. doi: 10.1002/pds.4629
Anthony MS , Getahun D, Alabaster AL, Cronkite D, Gatz J, Merchant M, Chiu VY, Armstrong MA, Ritchey ME, Fassett MJ, Schoendorf J, Asiimwe A. Feasibility of assessing breastfeeding status in electronic health records . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):122. doi: 10.1002/pds.4629
Ritchey ME, Postlethwaite D, Reed SD, Getahun DT, Gatz J, Lynen R, Saltus CW , Alabaster AL, Im TM, Takhar HS, Asiimwe A. Can electronic health records be used to identify medical procedure–related events indicative of difficult insertion of intrauterine devices? Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):219. doi: 10.1002/pds.4629
Ritchey ME, Hunter S, Peterson C, Nguyen L, Thomas S, Harding A , Andrews EB, Rothman KJ , Cainzos-Achirica M, Anthony MS . Cardiovascular safety of phentermine and topiramate in a United States claims database . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):449. doi: 10.1002/pds.4629
Kawai AT , Reidy M, Zichittella L, Stockdale C, Longley E, Walraven C, Liu C, Shoaibi A, Feibelmann S, Lee G. Developing the infrastructure to assess pregnancy outcomes following vaccination: influenza vaccines and spontaneous abortion as a use case . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):395. doi: 10.1002/pds.4629
Didden E-M, Andrews EB, Hellwig K, Hernandez-Diaz S, Magyari M, Margulis AV , Rivero-Ferrer E , Bader-Weder S, Wormser D. A novel approach for active surveillance of pregnancy safety in multiple sclerosis . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):268. doi: 10.1002/pds.4629
Panucci G, Chada K, Izurieta H, Shoaibi A, Said M, Forshee R, Obidi J, Petrone A, Cocoros N, Woodworth T, Kawai AT . Trends of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination during pregnancy in the Sentinel System . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26((Suppl. 2)):414.
Gutierrez L , Beachler DC, Overbeek J, McQuay L, Yin R, Kuiper J, McGrath L, Jemison J, Houben E, Lanes S, Gilsenan A , Herrings R. Characteristics of new users of dapagliflozin and other antidiabetic drugs: United States, United Kingdom, and the Netherlands . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):128.
Zografos LJ , Andrews EB, Wolin DL , Calingaert B , Davenport EK , Hollis KA , Petraro P, Djokanovic N, Racanelli VS, Vassilev Z. Evaluating physician knowledge of safety information for aflibercept (Eylea) . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):592. doi: 10.1002/pds
Pladevall M , Hallas J, Schink T, Morros R, Poblador-Plou B, Forns J , Hellfritzsch M, Reinders T, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Pottegard A, Kollhorst B, Cortes J, Aguado J , Perlemuter G, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S . Agomelatine and risk of hospitalization for acute liver injury: nested case-control study in Spain, Germany, and Denmark . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):389. doi: 10.1002/pds
Castellsague J, Calingaert B , Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Arana A , Bui C , Laguna C, Prados-Torres A, Roso-Llorach A, Perez-Gutthann S . Impact of risk minimization measures on the use of cilostazol in Europe . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):428. doi: 10.1002/pds
Hoffman V , Abu-Elyazeed R, Enger C, Esposito DB, Doherty M, Quinlan SC, Skerry K, Holick CN, Basile P, Friedland LR, Praet N, Wery S, Willame C, Dore DD, Rosillon D. An observational cohort study of live, oral, human rotavirus vaccine administered to infants in US health insurance plans . Poster presented at the 33nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):66.
Krueger WS, Anthony MS , Saltus CW , Margulis AV , Rivero-Ferrer E , Monz B, Wormser D, Andrews E. Existing databases useful for pregnancy exposure and fetal outcomes research, case study in multiple sclerosis (MS) . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):403. doi: 10.1002/pds
Cainzos-Achirica M, Varas-Lorenzo C, Pottegard A, Asmar J, Plana E , Rasmussen L, Bizouard G, Forns J , Hellfritzsch M, Zint K, Perez-Gutthann S , Pladevall-Vila M . Evaluation of potential off-label prescribing of dabigatran etexilate in France, Denmark, and the United Kingdom and associated methodological challenges . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):566. doi: 10.1002/pds
Arana A , Varas-Lorenzo C, McQuay LJ, Ziemiecki R , Bui CL , Gilsenan AW , Rothman KJ , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Margulis AV , Perez Gutthann S . Do individual antimuscarinic drugs to treat overactive bladder have different cardiovascular risks? A UK CPRD cohort study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):534-5.
Zografos LJ , Suzart K, Horvat-Broecker A, Soriano-Gabarro M, Wolin DL , Calingaer B , Davenport EK , Hollis KA , Andrews E. Evaluating physician knowledge of risks and safe use of Xarelto (rivaroxaban) . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):288-9.
Castellsague J, Calingaert B , Rothman KJ , Gutierrez L , van Herk-Sukel MPP, Kuiper JG, Pottegard A, Hallas J, Berglind IA, Sundstrom A, Dedman D, Gallagher A, Kaye JA, Pardo C, Perez-Gutthann S . Probabilistic bias analysis for unmeasured confounders in a study of users of topical tacrolimus, pimecrolimus, and corticosteroids (JOELLE) study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):142-3.
Castellsague J, Kuiper JJG, Pottegard A, Berglind IA, Dedman D, Gutierrez L , Calingaert B , van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Risk of lymphoma in users of topical tacrolimus, pimecrolimus and corticosteroids (JOELLE study) . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):494-5.
Castellsague J, van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Gutierrez L , Calingaert B , Kuiper JG, Pottegard A, Berglind IA, Dedman D, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Risk of skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids. JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):527.